Preston K L, Sullivan J T, Berger P, Bigelow G E
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland.
J Pharmacol Exp Ther. 1993 Oct;267(1):296-307.
Mazindol is a catecholamine reuptake inhibitor that blocks binding of cocaine at the dopamine reuptake site. This study was conducted to determine whether the acute administration of mazindol modulates the pharmacological effects of intravenous cocaine in humans. In a crossover study, twelve acute drug conditions were tested in randomized order under double-blind, double-dummy conditions in eight cocaine abusers. Cocaine (0, 12.5, 25 and 50 mg, i.v.) was administered in combination with mazindol (0, 1 and 2 mg given orally 2 hr before the cocaine injection). Physiological and subject- and observer-rated responses were measured. Cocaine and mazindol alone both significantly increased heart rate and blood pressure. Cocaine increased ratings on stimulant-like subjective effect measures, including desire for cocaine; mazindol had mild, stimulant-like subjective effects. There were significant interactions between the effects of cocaine and mazindol on heart rate and blood pressure, with combinations producing significantly large and more sustained increases compared with cocaine alone. There was no evidence that mazindol substantially altered the magnitude or profile of the subjective effects of cocaine, including cocaine-induced craving for cocaine. These results do not support the utility of acute administration of mazindol in the treatment of cocaine abusers through a mechanism of modulation of cocaine's subjective effects. Furthermore, mazindol treatment may increase the cardiovascular risks of cocaine.
马吲哚是一种儿茶酚胺再摄取抑制剂,可在多巴胺再摄取位点阻断可卡因的结合。本研究旨在确定急性给予马吲哚是否会调节静脉注射可卡因对人体的药理作用。在一项交叉研究中,对8名可卡因滥用者在双盲、双模拟条件下按随机顺序测试了12种急性药物情况。静脉注射可卡因(0、12.5、25和50毫克)并联合在注射可卡因前2小时口服马吲哚(0、1和2毫克)。测量了生理反应以及受试者和观察者评定的反应。单独使用可卡因和马吲哚均显著增加心率和血压。可卡因提高了类似兴奋剂的主观效应指标评分,包括对可卡因的渴望;马吲哚具有轻微的、类似兴奋剂的主观效应。可卡因和马吲哚对心率和血压的作用之间存在显著相互作用,与单独使用可卡因相比,联合使用时心率和血压升高幅度更大且更持久。没有证据表明马吲哚会实质性改变可卡因主观效应的程度或特征,包括可卡因引起的对可卡因的渴望。这些结果不支持通过调节可卡因主观效应的机制急性给予马吲哚用于治疗可卡因滥用者。此外,马吲哚治疗可能会增加可卡因的心血管风险。